Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

154 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Recruiting

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

NCT02416388

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CH Amiens Hôpital Sud Amiens, France
  • CHU Angers Angers, France
  • CH Victor Dupouy Argenteuil, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
View all 56 locations
View Trial Details
Recruiting

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

NCT05756777

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack Commack, New York, United States
View Trial Details
Recruiting

Ivosidenib as Post-HSCT Maintenance for AML

NCT06707493

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hematopoietic Stem Cell Transplant (HSCT), +7 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Ohio State University Wexner Medical Center- James Cancer Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

NCT07623616

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Chiba Aoba Municipal Hospital Chiba, Japan
  • Gifu Municipal Hospital Gifu, Japan
  • Hyogo Medical University Hospital Hyōgo, Japan
  • Mito Medical Center Ibaraki, Japan
View all 20 locations
View Trial Details
Recruiting

A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

NCT06372717

Conditions
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, +17 more
Locations
  • Monash Health Clayton, Victoria, Australia
  • St. Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
  • Hollywood Private Hospital Nedlands, Western Australia, Australia
View Trial Details
Recruiting

VABu Conditioning in Elderly AML HSCT

NCT07583888

Conditions
Acute Myeloid Leukemia (AML), Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Hematologic Diseases, +6 more
Locations
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
View Trial Details
Recruiting

An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

NCT05907057

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • AKH - Medizinische Universität Wien Vienna, Austria
  • Klinikum Wels-Grieskirchen GmbH Wels, Austria
  • Institut Paoli Calmettes Marseille, Bouches-du-Rhône, France
  • CHU CAEN - Hôpital de la Côte de Nacre Caen, Calvados, France
View all 15 locations
View Trial Details

Related conditions